Viewing Study NCT00606502


Ignite Creation Date: 2025-12-25 @ 3:53 AM
Ignite Modification Date: 2025-12-26 @ 2:43 AM
Study NCT ID: NCT00606502
Status: COMPLETED
Last Update Posted: 2021-03-05
First Post: 2008-01-22
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based Treatment
Sponsor: Spectrum Pharmaceuticals, Inc
Organization: